SC 13G Filing

Company

Eton Pharmaceuticals, Inc.

Filed

May 24, 2019

Accession Number

0001493152-19-008254

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →